Abstract:Objectives To investigate the role of Prx 1 in hepatocellular carcinoma. Methods The expression of Prx-1, pAkt and Akt in distal hepatocellular carcinoma and para- carcinoma tissue was detected by Western blot. Human liver cells were treated with 10 ng/ml EGF for 10 min after 24 hrs after serum starvation. Total proteins were extracted immediately after 10-min EGF treatment and used for Western blot. Equal amount of protein (20 μg) was separated by SDS-PAGE and probed with antibodies specific to Prx 1, pAkt, various phosphorylated forms of EGFR and total EGFR. Prx 1 protein levels in parental (untransfected), scramble, and Prx-1shRNA transfected HepG2 cells were measured by Western blot. Reactive oxygen species (ROS) levels determined from HepG2 sublines by using probe DCFH-DA. HepG2/Prx 1Sc and HepG2/Prx-1KD cells were injected into the dorsal flank of male SCID mice. Tumor size was measured every week after injection. Protein extracted from HepG2/Prx 1Sc and HepG2/Prx 1KD tumor tissues was subjected to Western blot analysis. Equal amount of protein (20 μg) was separated by SDS-PAGE and probed with antibodies specific to Prx-1and pAkt. Results Increased expression of Prx 1 was observed in abnormal (pre-malignant) liver cells compared to their paired normal liver cells. Prx 1 enhances EGF-mediated EGFR and Akt activation. Prx-1 knock-down inhibits tumor growth of HepG2 xenografts in vivo. Prx 1 knock-down reduces liver metastasis of HepG2 xenografts in vivo. Prx-1 knock-down inhibits Akt activation in vivo. Conclusions A potential role for Prx-1 in regulation of EGFR mediated signaling pathways in human liver cells. Prx-1 in mediates normal-to-abnormal cell transition, tumorigenesis, and metastasis through EGFR-Akt signaling pathways.